Ameriprise Financial Inc. Has $268.06 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Ameriprise Financial Inc. lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,915,953 shares of the medical device company's stock after selling 90,715 shares during the quarter. Ameriprise Financial Inc. owned about 1.46% of Cooper Companies worth $268,064,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. T. Rowe Price Investment Management Inc. lifted its stake in Cooper Companies by 2.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company's stock valued at $705,928,000 after buying an additional 155,233 shares during the period. JPMorgan Chase & Co. raised its position in shares of Cooper Companies by 1.5% in the 4th quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock valued at $460,066,000 after acquiring an additional 74,501 shares during the period. Geode Capital Management LLC raised its position in shares of Cooper Companies by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock valued at $449,907,000 after acquiring an additional 109,907 shares during the period. Victory Capital Management Inc. boosted its stake in Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after acquiring an additional 574,899 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after purchasing an additional 2,957,421 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Down 0.9 %

Cooper Companies stock opened at $81.57 on Tuesday. The company has a fifty day simple moving average of $81.25 and a 200 day simple moving average of $91.50. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The company has a market cap of $16.31 billion, a P/E ratio of 41.83, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Citigroup reduced their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Piper Sandler reiterated an "overweight" rating and set a $115.00 target price (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird lowered their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Finally, JPMorgan Chase & Co. decreased their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.